Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

bowmed ibisqus ltd - fluconazole - infusion - 2mg/1ml

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

bowmed ibisqus ltd - fluconazole - infusion - 2mg/1ml

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - mepolizumab 100 mg/ml - solution for injection - 100 mg/ml - active: mepolizumab 100 mg/ml excipient: citric acid monohydrate dibasic sodium phosphate heptahydrate disodium edetate polysorbate 80 sucrose water for injection - nucala is indicated as an add-on treatment for relapsing or refractory eosinophilic granulomatosis with polyangiitis (egpa) in adult patients aged 18 years and over.

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - mepolizumab 100 mg/ml - solution for injection - 100 mg/ml - active: mepolizumab 100 mg/ml excipient: citric acid monohydrate dibasic sodium phosphate heptahydrate disodium edetate polysorbate 80 sucrose water for injection - nucala is indicated as an add-on treatment for relapsing or refractory eosinophilic granulomatosis with polyangiitis (egpa) in adult patients aged 18 years and over.

Европейский союз - английский - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - linaclotide - irritable bowel syndrome - drugs for constipation - constella is indicated for the symptomatic treatment of moderate to severe irritable-bowel syndrome with constipation (ibs-c) in adults.

Соединенные Штаты - английский - NLM (National Library of Medicine)

baxalta us inc. - fibrinogen human (unii: n94833051k) (fibrinogen human - unii:n94833051k) - fibrinogen human 90 mg in 1 ml - tisseel is a fibrin sealant indicated for use as an adjunct to hemostasis in adult and pediatric patients (>1 month of age) undergoing surgery when control of bleeding by conventional surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical. tisseel is effective in heparinized patients. tisseel is a fibrin sealant indicated as an adjunct to standard surgical techniques (such as suture and ligature) to prevent leakage from colonic anastomoses following the reversal of temporary colostomies. do not inject tisseel directly into the circulatory system or into highly vascularized tissue. intravascular application of tisseel can lead to intravascular coagulation, can result in life-threatening thromboembolic events, and can increase the likelihood and severity of acute hypersensitivity reactions in susceptible patients (see warnings and precautions(5.3) and adverse reactions (6.2)).   do not use tisseel in individuals with a known hypersensitivity to aprotinin  (see warnings and pre

Соединенные Штаты - английский - NLM (National Library of Medicine)

baxalta us inc. - fibrinogen human (unii: n94833051k) (fibrinogen human - unii:n94833051k) - fibrinogen human 90 mg in 1 ml - tisseel is a fibrin sealant indicated for use as an adjunct to hemostasis in adult and pediatric patients (>1 month of age) undergoing surgery when control of bleeding by conventional surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical. tisseel is effective in heparinized patients. tisseel is a fibrin sealant indicated as an adjunct to standard surgical techniques (such as suture and ligature) to prevent leakage from colonic anastomoses following the reversal of temporary colostomies. do not inject tisseel directly into the circulatory system or into highly vascularized tissue. intravascular application of tisseel can lead to intravascular coagulation, can result in life-threatening thromboembolic events, and can increase the likelihood and severity of acute hypersensitivity reactions in susceptible patients (see warnings and precautions(5.3) and adverse reactions (6.2)).   do not use tisseel in individuals with a known hypersensitivity to aprotinin  (see warnings and pre

Соединенные Штаты - английский - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - tretinoin (unii: 5688utc01r) (tretinoin - unii:5688utc01r) - tretinoin gel microsphere is a retinoid indicated for topical application in the treatment of acne vulgaris. none. there are no adequate and well-controlled studies in pregnant women. tretinoin gel microsphere should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. thirty human cases of temporally associated congenital malformations have been reported during two decades of clinical use of tretinoin products. although no definite pattern of teratogenicity and no causal association has been established from these cases, five of the reports describe the rare birth defect category holoprosencephaly (defects associated with incomplete midline development of the forebrain). the significance of these spontaneous reports in terms of risk to the fetus is not known. for purposes of comparison of the animal exposure to systemic human exposure, the mrhd applied topically is defined as 1 gram of tretinoin gel microsphere , 0.1%, applied daily to a 60 kg person (0.017 mg t

Европейский союз - английский - EMA (European Medicines Agency)

bpl bioproducts laboratory gmbh - human coagulation factor x - factor x deficiency - vitamin k and other hemostatics, antihemorrhagics, coagulation factor x - coagadex is indicated for the treatment and prophylaxis of bleeding episodes and for perioperative management in patients with hereditary factor x deficiency. coagadex is indicated in all age groups.

Мальта - английский - Malta Medicines Authority

abbvie limited citywest business campus, dublin 24, ireland - powder for solution for injection - botulinum toxin type a 100 allergan units/0.1 millilitre - muscle relaxants